Recent Finacing
Recent Raise
Oxitec develops and deploys genetically engineered sterile male insects—primarily Aedes aegypti—carrying lethal and fluorescent marker genes to suppress disease-vector populations and enable field monitoring and broader pest control.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
